logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10067063 B1

PDFFull Text
Date of Patent:
Sep. 04, 2018

Filed:

Apr. 23, 2013

Prognosis and risk assessment in stroke patients by determining the level of marker peptides

Applicant:

B.r.a.h.m.s. Gmbh, Hennigsdorf, DE;

Inventors:

Andreas Bergmann, Berlin, DE;

Nils Morgenthaler, Berlin, DE;

Assignee:

B.R.A.H.M.S GMBH, Hennigsdorf, DE;

Attorney:

Millen White Zelano & Branigan, PC

Primary Examiner:

Zachary C Howard

Int. Cl.
CPC ...
G01N 33/53 (2006.01); A61P 9/10 (2006.01); G01N 21/76 (2006.01); G01N 33/68 (2006.01); C07K 14/575 (2006.01); C07K 14/58 (2006.01); C07K 14/61 (2006.01); C07K 7/16 (2006.01);
U.S. Cl.
CPC ...
G01N 21/76 (2013.01); A61P 9/10 (2018.01); G01N 33/53 (2013.01); G01N 33/6893 (2013.01); C07K 7/16 (2013.01); C07K 14/57527 (2013.01); C07K 14/57536 (2013.01); C07K 14/58 (2013.01); C07K 14/61 (2013.01); G01N 2333/4737 (2013.01); G01N 2333/58 (2013.01); G01N 2333/585 (2013.01); G01N 2333/59 (2013.01); G01N 2800/32 (2013.01);
Abstract

The present invention relates to a method for prognosis of an outcome or assessing the risk of a patient having suffered a stroke or a transient ischemic attack, comprising the determination of the level of at least one marker peptide in said sample said marker peptide selected from the group comprising ANP, AVP, ADM, ET-1, troponin, CRP, calcitonin and hGH or fragments thereof or its precursor or fragments thereof and attributing the level of said at least one marker peptides its precursor or fragments thereof with the prognosis of an outcome or assessing the risk for said patient.

Find Patent Forward Citations

Bergmann, Andreas. (2018). Prognosis and risk assessment in stroke patients by determining the level of marker peptides (U.S. Patent No. 10067063). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10067063

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…